CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67M96

Market Closed - Börse Stuttgart 01:16:19 07/06/2024 pm IST
118.2 EUR +0.15% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month+1.73%
1 month+0.05%
Date Price Change
07/24/07 118.2 +0.15%
06/24/06 118 +0.31%
05/24/05 117.6 +0.43%
04/24/04 117.1 +0.58%
03/24/03 116.4 +0.24%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 01:16 pm IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67M9
ISINDE000PC67M96
Date issued 25/03/2024
Strike 140 $
Maturity 20/06/2025 (378 Days)
Parity 1 : 1
Emission price 112.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 118.9
Lowest since issue 114.6
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.7 USD
Average target price
142.7 USD
Spread / Average Target
+9.19%
Consensus